Back to search
FDAFDA · Food and drugs·Recall number D-1009-2020

Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Published March 18, 2020 · Recall initiated: February 24, 2020

Summary

FDA records drug Class II recall D-1009-2020, published March 18, 2020 and initiated February 24, 2020. Recalling firm: Redline Pharmacy Solutions; Status: Terminated; Reported quantity: 8 doses; Lot: Lot 02242020@7. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack Of Processing Controls

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Redline Pharmacy Solutions
Distributor
Sold to patients in Nebraska
Lot
Lot 02242020@7
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 recalled?

Yes. FDA published recall D-1009-2020 on March 18, 2020. Reported hazard: Lack Of Processing Controls

What should I do if I have this product?

Voluntary: Firm initiated · Telephone